Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

9DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Rmc-4630, Rmc4630, 2172652-48-9, Shp2-in-7, Sar442720, Sar-442720

Molecular Formula

C₂₀H₂₇ClN₆O₂S

Molecular Weight

451.0 g/mol

InChI Key

HISJAYUQVHMWTA-BLLLJJGKSA-N

1 2D Structure

Vociprotafib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[6-(2-amino-3-chloropyridin-4-yl)sulfanyl-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl]methanol

2.1.2 InChI

InChI=1S/C20H27ClN6O2S/c1-11-19(30-14-3-6-24-17(23)15(14)21)26-13(9-28)18(25-11)27-7-4-20(5-8-27)10-29-12(2)16(20)22/h3,6,12,16,28H,4-5,7-10,22H2,1-2H3,(H2,23,24)/t12-,16+/m0/s1

2.1.3 InChI Key

HISJAYUQVHMWTA-BLLLJJGKSA-N

2.1.4 Canonical SMILES

CC1C(C2(CCN(CC2)C3=NC(=C(N=C3CO)SC4=C(C(=NC=C4)N)Cl)C)CO1)N

2.1.5 Isomeric SMILES

C[C@H]1[C@H](C2(CCN(CC2)C3=NC(=C(N=C3CO)SC4=C(C(=NC=C4)N)Cl)C)CO1)N

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Rmc-4630

2. Rmc4630

3. 2172652-48-9

4. Shp2-in-7

5. Sar442720

6. Sar-442720

7. [6-(2-amino-3-chloropyridin-4-yl)sulfanyl-3-[(3s,4s)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl]methanol

8. Vociprotafib [inn]

9. Unii-c4ybf9170l

10. C4ybf9170l

11. Schembl19785097

12. Gtpl12067

13. Ptpn11 Inhibitor Rmc-4630

14. Rmc 4630 [who-dd]

15. Glxc-25735

16. Ex-a5486

17. Nsc839698

18. Nsc-839698

19. Hy-141523

20. Cs-0179559

21. Compound A-290 [wo2018013597a1]

22. (6-((2-amino-3-chloropyridin-4-yl)sulfanyl)-3-((3s,4s)-4-amino- 3-methyl-2-oxa-8-azaspiro(4.5)decan-8-yl)- 5-methylpyrazin-2-yl)methanol

23. 2-pyrazinemethanol, 6-((2-amino-3-chloro-4-pyridinyl)thio)-3-((3s,4s)-4-amino-3-methyl-2-oxa-8-azaspiro(4.5)dec-8-yl)-5-methyl-

2.3 Create Date

2018-06-23

3 Chemical and Physical Properties

Molecular Formula	C₂₀H₂₇ClN₆O₂S
Molecular Weight	451.0 g/mol
XLogP3	1.2
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	4
Exact Mass	450.1604730 g/mol
Monoisotopic Mass	450.1604730 g/mol
Topological Polar Surface Area	149 Å²
Heavy Atom Count	30
Formal Charge	0
Complexity	584
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1